What is Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 (glucose-dependent insulinotropic polypeptide / glucagon-like peptide-1) receptor agonist. It is the first peptide to target both incretin receptors simultaneously, representing a novel approach to metabolic research.
The dual mechanism allows tirzepatide to leverage the complementary effects of both GIP and GLP-1 pathways. Research has shown synergistic effects on insulin secretion, glucagon regulation, appetite control, and energy metabolism.
The 15mg vial is a mid-size option providing flexibility for mid-protocol research, covering multiple weeks at moderate doses.
Quick Reference
| Parameter | Value |
|---|---|
| Peptide Amount | 15mg |
| Recommended BAC Water | 1.5mL |
| Resulting Concentration | 10mg/mL (10,000mcg/mL) |
| Typical Research Dose | 2.5mg - 15mg weekly |
| Frequency | Once weekly |
| Research Duration | 20-72 weeks |
Reconstitution Guide
Materials Needed
- Tirzepatide 15mg lyophilized vial
- Bacteriostatic water (BAC water)
- Insulin syringes (U-100, 29-31 gauge)
- Alcohol swabs
- Sharps container
Step-by-Step Instructions
-
Prepare your workspace — Clean your work area and gather all materials. Wash hands thoroughly.
-
Clean the vial stoppers — Wipe the Tirzepatide vial stopper and BAC water vial with alcohol swabs. Allow to dry.
-
Draw the BAC water — Using a sterile syringe, draw 1.5mL of bacteriostatic water.
-
Add water to peptide vial — Insert the needle and slowly inject BAC water down the inside wall of the vial. Never spray directly onto the powder.
-
Allow to dissolve — Tirzepatide typically dissolves within 5-10 minutes. Gently swirl if needed — never shake.
-
Verify dissolution — Solution should be clear and colorless. Discard if cloudy or particles visible.
-
Label and store — Write reconstitution date on vial. Refrigerate immediately.
Alternative Reconstitution Options
| BAC Water | Concentration | Best For |
|---|---|---|
| 1.5mL | 10mg/mL | Standard - easy math |
| 3mL | 5mg/mL | Lower concentration, more precision |
| 1mL | 15mg/mL | Smallest injection volumes |
Dosage Protocol
Concentration Calculations
With 15mg peptide in 1.5mL BAC water:
- Concentration: 10mg/mL = 10,000mcg/mL
- Per unit (U-100 syringe): 100mcg per unit
Common Dose Calculations
| Desired Dose | Draw Volume | Syringe Units |
|---|---|---|
| 2.5mg | 0.25mL | 25 units |
| 5.0mg | 0.50mL | 50 units |
| 7.5mg | 0.75mL | 75 units |
| 10mg | 1.00mL | 100 units |
| 12.5mg | 1.25mL | Use 2 draws |
| 15mg | 1.50mL | Full vial |
Doses Per Vial
At 10mg/mL concentration (1.5mL total = 15mg):
| Weekly Dose | Doses Per Vial | Duration |
|---|---|---|
| 2.5mg | 6 doses | 6 weeks |
| 5mg | 3 doses | 3 weeks |
| 7.5mg | 2 doses | 2 weeks |
| 10mg | 1.5 doses | ~1.5 weeks |
| 15mg | 1 dose | 1 week |
Suggested Titration Protocol
Tirzepatide research protocols employ gradual escalation:
| Week | Dose | Syringe Units | Notes |
|---|---|---|---|
| 1-4 | 2.5mg | 25 units | Initial titration |
| 5-8 | 5mg | 50 units | First escalation |
| 9-12 | 7.5mg | 75 units | Second escalation |
| 13-16 | 10mg | 100 units | Third escalation |
| 17-20 | 12.5mg | 125 units | Fourth escalation |
| 21+ | 15mg | 150 units | Maximum dose (if tolerated) |
Important Notes:
- Minimum 4 weeks at each dose level before escalation
- Many protocols plateau at 10mg or 12.5mg
- The 15mg vial provides good flexibility across mid-range doses
Injection Guide
Subcutaneous Administration
- Clean injection site with alcohol swab and let dry
- Pinch skin fold at abdomen, thigh, or upper arm
- Insert needle at 90° angle
- Inject slowly over 5-10 seconds
- Wait 10 seconds before withdrawing
- Apply gentle pressure — do not massage
Site Rotation
Rotate weekly between:
- Abdomen (preferred) — avoid 2-inch radius around navel
- Front/outer thigh
- Back of upper arm
Large Volume Injections
For doses at 10mg or above (≥1mL volume):
- Consider splitting into 2 injections at different sites
- Complete all injections within 15-minute window
Storage Requirements
Lyophilized (Powder Form)
- Temperature: -20°C (-4°F) or colder
- Duration: 2+ years
- Conditions: Protect from light and moisture
Reconstituted (Mixed with BAC Water)
- Temperature: 2-8°C (36-46°F)
- Duration: 4-6 weeks
- Conditions: Protect from light, never freeze
Research Considerations
Dual Mechanism of Action
Tirzepatide’s unique dual-receptor approach:
GIP Receptor Activation:
- Enhanced insulin secretion
- Improved beta-cell function
- Potential adipose tissue effects
GLP-1 Receptor Activation:
- Appetite suppression
- Delayed gastric emptying
- Glucagon suppression
Why Choose 15mg Vials
The 15mg vial is ideal for:
- Mid-protocol flexibility — Covers doses from 2.5mg to 15mg
- Titration through moderate doses — 6 weeks at 2.5mg or 3 weeks at 5mg per vial
- Cost balance — More economical than multiple 5mg vials, less commitment than 30mg
- Testing higher doses — Good for protocols progressing toward 10-15mg range
Sourcing for Research
Source from verified suppliers that provide third-party testing and certificates of analysis (COA) for each batch. Compare purity documentation, shipping conditions, and batch traceability before purchasing research materials.
Scientific References
- Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” N Engl J Med. 2022;387:205-216.
- Frías JP, et al. “Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.” N Engl J Med. 2021;385:503-515.
- Samms RJ, et al. “How May GIP Enhance the Therapeutic Efficacy of GLP-1?” Trends Endocrinol Metab. 2020;31:410-421.
Last updated: December 03, 2025
Disclaimer: This information is for educational and research purposes only. Tirzepatide as a research peptide is not intended for human consumption. Pharmaceutical tirzepatide (Mounjaro®, Zepbound®) requires a prescription. Always follow applicable laws and institutional guidelines.